How do you approach the diagnostic evaluation of osteoporosis in CKD when renal dysfunction limits use of certain tests or biomarkers?

This question is part of our collaboration with ACR Convergence 2025 to Continue the Conversation from the meeting. This question was inspired by the session "Updates in Osteoporosis: Where They 'Fall Short" by Dr. @Dr. First Last and Dr. @Dr. First Last. If you did not attend the meeting, information about Convergence On Demand can be found here.